Leaflet SINERDOL 150mg capsules


Indicated for: tuberculosis

Route of administration: oral

Substance: rifampicin (anti-tuberculosis agent)

ATC: J04AB02 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics)

Rifampicin is an antibiotic primarily used to treat tuberculosis and other severe bacterial infections, such as leprosy or infections caused by Staphylococcus aureus. It belongs to the rifamycin class and works by inhibiting bacterial RNA synthesis, effectively killing the bacteria.

It is an essential medication in tuberculosis treatment, used in combination with other antibiotics to prevent bacterial resistance. Rifampicin is also used to prevent bacterial meningitis in individuals exposed to Neisseria meningitidis.

Side effects may include nausea, abdominal pain, orange discoloration of urine, tears, or saliva, and, more rarely, liver function impairment. Patients must strictly follow the prescribed treatment regimen to avoid the development of bacterial resistance.

Rifampicin should not be used without medical supervision, as it interacts with many other medications and may reduce their effectiveness.

General data about SINERDOL 150mg

  • Substance: rifampicin
  • Date of last drug list: 01-05-2026
  • Commercial code: W41998002
  • Concentration: 150mg
  • Pharmaceutical form: capsules
  • Quantity: 1000
  • Product type: generic
  • Price: 590.34 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ANTIBIOTICE SA - ROMANIA
  • Holder: ANTIBIOTICE SA - ROMANIA
  • Number: 9186/2016/02
  • Shelf life: 4 years

Concentrations available for rifampicin

  • 150mg
  • 300mg

Compensation lists for SINERDOL 150mg Antibiotice

NHP 1.B (C2) - Tuberculosis

Price

Copayment

Patient

590.34 RON

590.34 RON

0.00 RON